3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
6
Neoplasms
6
Multiple Myeloma
4
Fractures, Bone
4
Osteoporosis
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Giant Cell Tumor of Bone
2
Bone Metastases
2
Bone Diseases
2
Parathyroid Neoplasms
1
Paraproteinemias
1
Neoplastic Processes
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Mastocytosis, Systemic
1
Lymphoma
1
Hyperparathyroidism, Primary
1
Hormone Refractory Prostate Cancer
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Cataract
1
Castrate-resistant Prostate Cancer
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Diseases
1
Bone Neoplasms
1
Interventions
Cinacalcet
2
evocalcet
1
Tablets
1
Sodium Chloride
1
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Parathyroid Neoplasms
×
Denosumab
×
Clear all
NCT03027557
2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3
Completed
46 enrolled
49 charts